
Kiora Pharmaceuticals Investor Relations Material
Latest events

Study Result
Kiora Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Kiora Pharmaceuticals Inc
Access all reports
Kiora Pharmaceuticals Inc is a U.S.-based clinical-stage biopharmaceutical company focused on developing treatments for ophthalmic diseases. The company’s pipeline includes therapies targeting eye conditions such as dry eye disease, retinal disorders, and ocular inflammation. Kiora develops both small molecules and biologics aimed at addressing unmet medical needs in vision care. The company conducts clinical trials and engages in research partnerships to advance its product candidates. Kiora Pharmaceuticals Inc is headquartered in Encinitas, California, and its shares are listed on the NASDAQ.
Key slides for Kiora Pharmaceuticals Inc


Lytham Partners Fall 2024 Investor Conference
Kiora Pharmaceuticals Inc


Lytham Partners Fall 2024 Investor Conference
Kiora Pharmaceuticals Inc
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
KPRX
Country
🇺🇸 United States